DIN 00616192 — VEPESID 50 MG
VEPESID is a capsule of Etoposide marketed by CHEPLAPHARM ARZNEIMITTEL GMBH. The full Etoposide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00616192
- Brand name
- VEPESID
- Active ingredient
- Etoposide
- Strength
- 50 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Health Canada status
- MARKETED
- Drug class
- Topoisomerase II inhibitor (antineoplastic agent, podophyllotoxin derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Etoposide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02080036 | ETOPOSIDE INJECTION | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02239961 | ETOPOSIDE INJECTION | 20 MG | LIQUID | FRESENIUS KABI CANADA LTD | DORMANT |
| 02552671 | ETOPOSIDE INJECTION | 20 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 02422530 | ETOPOSIDE INJECTION, USP | 20 MG | SOLUTION | STRIDES PHARMA CANADA INC | DORMANT |